Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
51
FFTY Quote, Financials, Valuation and Earnings
Last price:
$36.20
Seasonality move
:
0.67%
Day range:
$36.00 - $36.24
52-week range:
$22.91 - $41.36
Dividend yield:
0.72%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
54.7K
Avg. volume:
148.1K
1-year change:
18.72%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
FFTY
Innovator IBD 50 ETF
|
-- | -- | -- | -- | -- |
|
FPX
First Trust US Equity Opportunities ETF
|
-- | -- | -- | -- | -- |
|
GURU
Global X Guru Index ETF
|
-- | -- | -- | -- | -- |
|
IPO
Renaissance IPO ETF
|
-- | -- | -- | -- | -- |
|
MDYG
State Street SPDR S&P 400 Mid Cap Growth ETF
|
-- | -- | -- | -- | -- |
|
ONEO
State Street SPDR Russell 1000 Momentum Focus ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
FFTY
Innovator IBD 50 ETF
|
$36.21 | -- | -- | -- | $0.26 | 0.72% | -- |
|
FPX
First Trust US Equity Opportunities ETF
|
$169.31 | -- | -- | -- | $0.23 | 0.51% | -- |
|
GURU
Global X Guru Index ETF
|
$64.21 | -- | -- | -- | $0.02 | 0.15% | -- |
|
IPO
Renaissance IPO ETF
|
$46.89 | -- | -- | -- | $0.18 | 0.72% | -- |
|
MDYG
State Street SPDR S&P 400 Mid Cap Growth ETF
|
$94.63 | -- | -- | -- | $0.19 | 0.73% | -- |
|
ONEO
State Street SPDR Russell 1000 Momentum Focus ETF
|
$131.55 | -- | -- | -- | $0.45 | 1.27% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
FFTY
Innovator IBD 50 ETF
|
-- | 1.833 | -- | -- |
|
FPX
First Trust US Equity Opportunities ETF
|
-- | 1.967 | -- | -- |
|
GURU
Global X Guru Index ETF
|
-- | 1.097 | -- | -- |
|
IPO
Renaissance IPO ETF
|
-- | 1.770 | -- | -- |
|
MDYG
State Street SPDR S&P 400 Mid Cap Growth ETF
|
-- | 1.162 | -- | -- |
|
ONEO
State Street SPDR Russell 1000 Momentum Focus ETF
|
-- | 0.893 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
FFTY
Innovator IBD 50 ETF
|
-- | -- | -- | -- | -- | -- |
|
FPX
First Trust US Equity Opportunities ETF
|
-- | -- | -- | -- | -- | -- |
|
GURU
Global X Guru Index ETF
|
-- | -- | -- | -- | -- | -- |
|
IPO
Renaissance IPO ETF
|
-- | -- | -- | -- | -- | -- |
|
MDYG
State Street SPDR S&P 400 Mid Cap Growth ETF
|
-- | -- | -- | -- | -- | -- |
|
ONEO
State Street SPDR Russell 1000 Momentum Focus ETF
|
-- | -- | -- | -- | -- | -- |
Innovator IBD 50 ETF vs. Competitors
-
Which has Higher Returns FFTY or FPX?
First Trust US Equity Opportunities ETF has a net margin of -- compared to Innovator IBD 50 ETF's net margin of --. Innovator IBD 50 ETF's return on equity of -- beat First Trust US Equity Opportunities ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FFTYInnovator IBD 50 ETF-- -- -- FPXFirst Trust US Equity Opportunities ETF-- -- -- -
What do Analysts Say About FFTY or FPX?
Innovator IBD 50 ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust US Equity Opportunities ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Innovator IBD 50 ETF has higher upside potential than First Trust US Equity Opportunities ETF, analysts believe Innovator IBD 50 ETF is more attractive than First Trust US Equity Opportunities ETF.
Company Buy Ratings Hold Ratings Sell Ratings FFTYInnovator IBD 50 ETF0 0 0 FPXFirst Trust US Equity Opportunities ETF0 0 0 -
Is FFTY or FPX More Risky?
Innovator IBD 50 ETF has a beta of 1.405, which suggesting that the stock is 40.503% more volatile than S&P 500. In comparison First Trust US Equity Opportunities ETF has a beta of 1.235, suggesting its more volatile than the S&P 500 by 23.497%.
-
Which is a Better Dividend Stock FFTY or FPX?
Innovator IBD 50 ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0.72%. First Trust US Equity Opportunities ETF offers a yield of 0.51% to investors and pays a quarterly dividend of $0.23 per share. Innovator IBD 50 ETF pays -- of its earnings as a dividend. First Trust US Equity Opportunities ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FFTY or FPX?
Innovator IBD 50 ETF quarterly revenues are --, which are smaller than First Trust US Equity Opportunities ETF quarterly revenues of --. Innovator IBD 50 ETF's net income of -- is lower than First Trust US Equity Opportunities ETF's net income of --. Notably, Innovator IBD 50 ETF's price-to-earnings ratio is -- while First Trust US Equity Opportunities ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovator IBD 50 ETF is -- versus -- for First Trust US Equity Opportunities ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FFTYInnovator IBD 50 ETF-- -- -- -- FPXFirst Trust US Equity Opportunities ETF-- -- -- --
-
Which has Higher Returns FFTY or GURU?
Global X Guru Index ETF has a net margin of -- compared to Innovator IBD 50 ETF's net margin of --. Innovator IBD 50 ETF's return on equity of -- beat Global X Guru Index ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FFTYInnovator IBD 50 ETF-- -- -- GURUGlobal X Guru Index ETF-- -- -- -
What do Analysts Say About FFTY or GURU?
Innovator IBD 50 ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Guru Index ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Innovator IBD 50 ETF has higher upside potential than Global X Guru Index ETF, analysts believe Innovator IBD 50 ETF is more attractive than Global X Guru Index ETF.
Company Buy Ratings Hold Ratings Sell Ratings FFTYInnovator IBD 50 ETF0 0 0 GURUGlobal X Guru Index ETF0 0 0 -
Is FFTY or GURU More Risky?
Innovator IBD 50 ETF has a beta of 1.405, which suggesting that the stock is 40.503% more volatile than S&P 500. In comparison Global X Guru Index ETF has a beta of 0.997, suggesting its less volatile than the S&P 500 by 0.321%.
-
Which is a Better Dividend Stock FFTY or GURU?
Innovator IBD 50 ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0.72%. Global X Guru Index ETF offers a yield of 0.15% to investors and pays a quarterly dividend of $0.02 per share. Innovator IBD 50 ETF pays -- of its earnings as a dividend. Global X Guru Index ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FFTY or GURU?
Innovator IBD 50 ETF quarterly revenues are --, which are smaller than Global X Guru Index ETF quarterly revenues of --. Innovator IBD 50 ETF's net income of -- is lower than Global X Guru Index ETF's net income of --. Notably, Innovator IBD 50 ETF's price-to-earnings ratio is -- while Global X Guru Index ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovator IBD 50 ETF is -- versus -- for Global X Guru Index ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FFTYInnovator IBD 50 ETF-- -- -- -- GURUGlobal X Guru Index ETF-- -- -- --
-
Which has Higher Returns FFTY or IPO?
Renaissance IPO ETF has a net margin of -- compared to Innovator IBD 50 ETF's net margin of --. Innovator IBD 50 ETF's return on equity of -- beat Renaissance IPO ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FFTYInnovator IBD 50 ETF-- -- -- IPORenaissance IPO ETF-- -- -- -
What do Analysts Say About FFTY or IPO?
Innovator IBD 50 ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Renaissance IPO ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Innovator IBD 50 ETF has higher upside potential than Renaissance IPO ETF, analysts believe Innovator IBD 50 ETF is more attractive than Renaissance IPO ETF.
Company Buy Ratings Hold Ratings Sell Ratings FFTYInnovator IBD 50 ETF0 0 0 IPORenaissance IPO ETF0 0 0 -
Is FFTY or IPO More Risky?
Innovator IBD 50 ETF has a beta of 1.405, which suggesting that the stock is 40.503% more volatile than S&P 500. In comparison Renaissance IPO ETF has a beta of 1.234, suggesting its more volatile than the S&P 500 by 23.379%.
-
Which is a Better Dividend Stock FFTY or IPO?
Innovator IBD 50 ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0.72%. Renaissance IPO ETF offers a yield of 0.72% to investors and pays a quarterly dividend of $0.18 per share. Innovator IBD 50 ETF pays -- of its earnings as a dividend. Renaissance IPO ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FFTY or IPO?
Innovator IBD 50 ETF quarterly revenues are --, which are smaller than Renaissance IPO ETF quarterly revenues of --. Innovator IBD 50 ETF's net income of -- is lower than Renaissance IPO ETF's net income of --. Notably, Innovator IBD 50 ETF's price-to-earnings ratio is -- while Renaissance IPO ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovator IBD 50 ETF is -- versus -- for Renaissance IPO ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FFTYInnovator IBD 50 ETF-- -- -- -- IPORenaissance IPO ETF-- -- -- --
-
Which has Higher Returns FFTY or MDYG?
State Street SPDR S&P 400 Mid Cap Growth ETF has a net margin of -- compared to Innovator IBD 50 ETF's net margin of --. Innovator IBD 50 ETF's return on equity of -- beat State Street SPDR S&P 400 Mid Cap Growth ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FFTYInnovator IBD 50 ETF-- -- -- MDYGState Street SPDR S&P 400 Mid Cap Growth ETF-- -- -- -
What do Analysts Say About FFTY or MDYG?
Innovator IBD 50 ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street SPDR S&P 400 Mid Cap Growth ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Innovator IBD 50 ETF has higher upside potential than State Street SPDR S&P 400 Mid Cap Growth ETF, analysts believe Innovator IBD 50 ETF is more attractive than State Street SPDR S&P 400 Mid Cap Growth ETF.
Company Buy Ratings Hold Ratings Sell Ratings FFTYInnovator IBD 50 ETF0 0 0 MDYGState Street SPDR S&P 400 Mid Cap Growth ETF0 0 0 -
Is FFTY or MDYG More Risky?
Innovator IBD 50 ETF has a beta of 1.405, which suggesting that the stock is 40.503% more volatile than S&P 500. In comparison State Street SPDR S&P 400 Mid Cap Growth ETF has a beta of 1.086, suggesting its more volatile than the S&P 500 by 8.569%.
-
Which is a Better Dividend Stock FFTY or MDYG?
Innovator IBD 50 ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0.72%. State Street SPDR S&P 400 Mid Cap Growth ETF offers a yield of 0.73% to investors and pays a quarterly dividend of $0.19 per share. Innovator IBD 50 ETF pays -- of its earnings as a dividend. State Street SPDR S&P 400 Mid Cap Growth ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FFTY or MDYG?
Innovator IBD 50 ETF quarterly revenues are --, which are smaller than State Street SPDR S&P 400 Mid Cap Growth ETF quarterly revenues of --. Innovator IBD 50 ETF's net income of -- is lower than State Street SPDR S&P 400 Mid Cap Growth ETF's net income of --. Notably, Innovator IBD 50 ETF's price-to-earnings ratio is -- while State Street SPDR S&P 400 Mid Cap Growth ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovator IBD 50 ETF is -- versus -- for State Street SPDR S&P 400 Mid Cap Growth ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FFTYInnovator IBD 50 ETF-- -- -- -- MDYGState Street SPDR S&P 400 Mid Cap Growth ETF-- -- -- --
-
Which has Higher Returns FFTY or ONEO?
State Street SPDR Russell 1000 Momentum Focus ETF has a net margin of -- compared to Innovator IBD 50 ETF's net margin of --. Innovator IBD 50 ETF's return on equity of -- beat State Street SPDR Russell 1000 Momentum Focus ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FFTYInnovator IBD 50 ETF-- -- -- ONEOState Street SPDR Russell 1000 Momentum Focus ETF-- -- -- -
What do Analysts Say About FFTY or ONEO?
Innovator IBD 50 ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street SPDR Russell 1000 Momentum Focus ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Innovator IBD 50 ETF has higher upside potential than State Street SPDR Russell 1000 Momentum Focus ETF, analysts believe Innovator IBD 50 ETF is more attractive than State Street SPDR Russell 1000 Momentum Focus ETF.
Company Buy Ratings Hold Ratings Sell Ratings FFTYInnovator IBD 50 ETF0 0 0 ONEOState Street SPDR Russell 1000 Momentum Focus ETF0 0 0 -
Is FFTY or ONEO More Risky?
Innovator IBD 50 ETF has a beta of 1.405, which suggesting that the stock is 40.503% more volatile than S&P 500. In comparison State Street SPDR Russell 1000 Momentum Focus ETF has a beta of 0.998, suggesting its less volatile than the S&P 500 by 0.175%.
-
Which is a Better Dividend Stock FFTY or ONEO?
Innovator IBD 50 ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0.72%. State Street SPDR Russell 1000 Momentum Focus ETF offers a yield of 1.27% to investors and pays a quarterly dividend of $0.45 per share. Innovator IBD 50 ETF pays -- of its earnings as a dividend. State Street SPDR Russell 1000 Momentum Focus ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FFTY or ONEO?
Innovator IBD 50 ETF quarterly revenues are --, which are smaller than State Street SPDR Russell 1000 Momentum Focus ETF quarterly revenues of --. Innovator IBD 50 ETF's net income of -- is lower than State Street SPDR Russell 1000 Momentum Focus ETF's net income of --. Notably, Innovator IBD 50 ETF's price-to-earnings ratio is -- while State Street SPDR Russell 1000 Momentum Focus ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovator IBD 50 ETF is -- versus -- for State Street SPDR Russell 1000 Momentum Focus ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FFTYInnovator IBD 50 ETF-- -- -- -- ONEOState Street SPDR Russell 1000 Momentum Focus ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
